Post-thrombotic syndrome secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Post-thrombotic syndrome}} | {{Post-thrombotic syndrome}} | ||
Endovascular stenting of the iliac vein may help.<ref name="pmid29292114 ">{{cite journal | last=Rossi | first=Fabio H. | last2=Kambara | first2=Antonio M. | last3=Izukawa | first3=Nilo M. | last4=Rodrigues | first4=Thiago O. | last5=Rossi | first5=Cybelle B. | last6=Sousa | first6=Amanda G. | last7=Metzger | first7=Patrick B. | last8=Thorpe | first8=Patricia E. | title=Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease | journal=Journal of Vascular Surgery. Venous and Lymphatic Disorders | volume=6 | issue=2 | date=2018 | issn=2213-3348 | pmid=29292114 | doi=10.1016/j.jvsv.2017.11.003 | pages=183–191}}</ref> | Endovascular stenting of the iliac vein may help.<ref name="pmid29292114 ">{{cite journal | last=Rossi | first=Fabio H. | last2=Kambara | first2=Antonio M. | last3=Izukawa | first3=Nilo M. | last4=Rodrigues | first4=Thiago O. | last5=Rossi | first5=Cybelle B. | last6=Sousa | first6=Amanda G. | last7=Metzger | first7=Patrick B. | last8=Thorpe | first8=Patricia E. | title=Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease | journal=Journal of Vascular Surgery. Venous and Lymphatic Disorders | volume=6 | issue=2 | date=2018 | issn=2213-3348 | pmid=29292114 | doi=10.1016/j.jvsv.2017.11.003 | pages=183–191}}</ref> Adding [[aspirin]] to concomitant [[anticoagulation]] did not help in a [[randomized controlled trial]]<ref name="p162">{{cite journal | last=Barco | first=Stefano | last2=Jalaie | first2=Houman | last3=Sebastian | first3=Tim | last4=Wolf | first4=Simon | last5=Fumagalli | first5=Riccardo M. | last6=Lichtenberg | first6=Michael | last7=Zeller | first7=Thomas | last8=Erbel | first8=Christian | last9=Schlager | first9=Oliver | last10=Kucher | first10=Nils | title=Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis Among Patients With Post-Thrombotic Syndrome: The Multicenter, Multinational, Randomized, Open-Label ARIVA Trial | journal=Circulation | volume=151 | issue=12 | date=2025-03-25 | issn=1524-4539 | pmid=39874026 | doi=10.1161/CIRCULATIONAHA.124.073050 | pages=835–846}}</ref>. | ||
==References== | ==References== | ||
Latest revision as of 15:12, 28 March 2025
|
Post-thrombotic syndrome Microchapters |
|
Differentiating Post-thrombotic syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Post-thrombotic syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Post-thrombotic syndrome secondary prevention |
|
Risk calculators and risk factors for Post-thrombotic syndrome secondary prevention |
Endovascular stenting of the iliac vein may help.[1] Adding aspirin to concomitant anticoagulation did not help in a randomized controlled trial[2].
References
- ↑ Rossi, Fabio H.; Kambara, Antonio M.; Izukawa, Nilo M.; Rodrigues, Thiago O.; Rossi, Cybelle B.; Sousa, Amanda G.; Metzger, Patrick B.; Thorpe, Patricia E. (2018). "Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease". Journal of Vascular Surgery. Venous and Lymphatic Disorders. 6 (2): 183–191. doi:10.1016/j.jvsv.2017.11.003. ISSN 2213-3348. PMID 29292114.
- ↑ Barco, Stefano; Jalaie, Houman; Sebastian, Tim; Wolf, Simon; Fumagalli, Riccardo M.; Lichtenberg, Michael; Zeller, Thomas; Erbel, Christian; Schlager, Oliver; Kucher, Nils (2025-03-25). "Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis Among Patients With Post-Thrombotic Syndrome: The Multicenter, Multinational, Randomized, Open-Label ARIVA Trial". Circulation. 151 (12): 835–846. doi:10.1161/CIRCULATIONAHA.124.073050. ISSN 1524-4539. PMID 39874026 Check
|pmid=value (help).